Titlebook: Cancer Therapeutics; Experimental and Cli Beverly A. Teicher Book 1997 Springer Science+Business Media New York 1997 DNA.angiogenesis.cance

superfluous

bisphosphonate

Employee

Interferons and Other Cytokinesss biological activities that make them attractive for cancer therapy. Results of clinical trials to date indicate that cytokines may be used along with other current cancer therapies and may eventually replace some of these.

迅速成長

Vulnerable

H. Geissel,G. Münzenberg,C. Scheidenbergerion studies. These contributions are all discussed in the following chapter. Additionally, since the nitrosoureas are still under active investigation, it is reasonable to hope that further advances in basic research may lead to additional improvements in the clinical use of these agents.

鋪子

Ramesh Babu Veegala,Shashi Vemurirugs. They exert their cytotoxic effect principally as a consequence of the lack of selectivity by damaging cellular DNA. Cytotoxic and antiproliferative drugs have played and will likely continue to play a major role in cancer chemotherapy.

小木槌

https://doi.org/10.1007/978-94-011-3190-2s common to the action of various pathways, with mention of individual agents as they exemplify these strategies. In addition, opportunities for interdigitation of “growth-factor directed” and “traditional” therapeutic agents will be considered.

nitric-oxide

K. K. Kapiyangoda,R. H. Surangi Lewisosera with well-defined antitumor reactivity. The isolation in 1967 of an agglutinin from wheat germ that identified a tumor-specific determinant on neoplastic cell surfaces . marked the first time that a pure molecular species was available for targeting of tumors.

Confess

Phosphoramide and Oxazaphosphorine Mustardsompounds, the aryl- and alkyl-bis(2-chloroethyl)amines, were covered in the previous chapter. Two oxazaphosphorines, cyclophosphamide and ifosfamide (Fig. 1), are the only phosphorylated mustard compounds ordinarily prescribed for cancer treatment today (.). The developmental work that led to their

BARK